Abattis Bioceuticals (Abattis Bioceuticals) Scaled Net Operating Assets : 0.48 (As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Abattis Bioceuticals's operating assets for the quarter that ended in Sep. 2019 was $12.73 Mil. Abattis Bioceuticals's operating liabilities for the quarter that ended in Sep. 2019 was $5.30 Mil. Abattis Bioceuticals's Total Assets for the quarter that ended in Jun. 2019 was $15.36 Mil. Therefore, Abattis Bioceuticals's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2019 was 0.48.

Abattis Bioceuticals Scaled Net Operating Assets Historical Data

The historical data trend for Abattis Bioceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Scaled Net Operating Assets Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.03

0.13

0.21

1.56

0.85

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.03	0.60	0.62	0.74	0.48

Competitive Comparison of Abattis Bioceuticals's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Abattis Bioceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abattis Bioceuticals's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abattis Bioceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Abattis Bioceuticals's Scaled Net Operating Assets falls into.

Abattis Bioceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Abattis Bioceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Sep. 2019 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Sep. 2019 )
=	(Operating Assets (A: Sep. 2019 )	-	Operating Liabilities (A: Sep. 2019 ))	/	Total Assets (A: Sep. 2018 )
=	(12.732	-	5.304)	/	8.746
=	0.85

where

	Operating Assets		(A: Sep. 2019 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	14.546	-	1.814
=	12.732

	Operating Liabilities		(A: Sep. 2019 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	6.49	-	0.094	-	1.092
=	5.304

Abattis Bioceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2019 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2019 )
=	(Operating Assets (Q: Sep. 2019 )	-	Operating Liabilities (Q: Sep. 2019 ))	/	Total Assets (Q: Jun. 2019 )
=	(12.732	-	5.304)	/	15.359
=	0.48

where

	Operating Assets		(Q: Sep. 2019 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	14.546	-	1.814
=	12.732

	Operating Liabilities		(Q: Sep. 2019 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	6.49	-	0.094	-	1.092
=	5.304

Abattis Bioceuticals Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.